Variant report
Variant | nsv514733 |
---|---|
Chromosome Location | chr14:22053460-22055732 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:6)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:6 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | MAFK | chr14:22054917-22055048 | HepG2 | liver: | n/a | chr14:22054927-22054942 |
2 | MAFK | chr14:22054906-22055075 | HepG2 | liver: | n/a | chr14:22054927-22054942 |
3 | MYC | chr14:22054999-22055033 | MCF-7 | breast: | n/a | n/a |
4 | MYC | chr14:22054981-22054996 | MCF-7 | breast: | n/a | n/a |
5 | POLR2A | chr14:22054919-22055057 | MCF-7 | breast: | n/a | n/a |
6 | ZNF143 | chr14:22053542-22053628 | K562 | blood: | n/a | n/a |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-OR10G3-1 | chr14:22053414-22054404 | NONHSAT035698 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000256081 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs570473197 | chr14:22053482-22053483 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs373638953 | chr14:22053513-22053514 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs115766144 | chr14:22053529-22053530 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs116133752 | chr14:22053628-22053629 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs6571922 | chr14:22053675-22053676 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs17182620 | chr14:22053729-22053730 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs35633348 | chr14:22053782-22053783 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs551068418 | chr14:22053806-22053807 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs6571924 | chr14:22053817-22053818 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs531879699 | chr14:22053818-22053819 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs6571925 | chr14:22053863-22053864 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
12 | rs185847178 | chr14:22053921-22053922 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs17254834 | chr14:22053923-22053924 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs563669592 | chr14:22053970-22053971 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs190648666 | chr14:22054025-22054026 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs182385798 | chr14:22054033-22054034 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs187992027 | chr14:22054049-22054050 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs192613514 | chr14:22054080-22054081 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs552119445 | chr14:22054114-22054115 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs148696935 | chr14:22054130-22054131 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs567153731 | chr14:22054131-22054132 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs142201401 | chr14:22054154-22054155 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs151145974 | chr14:22054169-22054170 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs140208969 | chr14:22054187-22054188 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs182629099 | chr14:22054197-22054198 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs571916978 | chr14:22054265-22054266 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs540791094 | chr14:22054321-22054322 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs557649349 | chr14:22054322-22054323 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs577502981 | chr14:22054339-22054340 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs11624849 | chr14:22054353-22054354 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs8022134 | chr14:22054398-22054399 | Weak transcription | lncRNA | n/a | Overlapped CNVs | mRNA abundance |
32 | rs571309253 | chr14:22054426-22054427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs567489553 | chr14:22054441-22054442 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs75505812 | chr14:22054448-22054449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs573906291 | chr14:22054451-22054452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs187997740 | chr14:22054471-22054472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs11847952 | chr14:22054477-22054478 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs556595457 | chr14:22054490-22054491 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs192514041 | chr14:22054552-22054553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs528718418 | chr14:22054561-22054562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs372592006 | chr14:22054567-22054568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs551982807 | chr14:22054597-22054598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs185079200 | chr14:22054613-22054614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs531226101 | chr14:22054662-22054663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs143987693 | chr14:22054683-22054684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs569635277 | chr14:22054696-22054697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs11624979 | chr14:22054718-22054719 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs188913707 | chr14:22054720-22054721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs565405760 | chr14:22054721-22054722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs534534110 | chr14:22054723-22054724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cone-rod dystrophy | 18421352 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Alzheimer''s disease | 21482944 | CNVD |
Mental retardation | 19951919 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Heart disease | 21282601 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Lung cancer | 16773561 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 17440070 | CNVD |
Breast cancer | 16272173 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Epilepsy | 20736978 | CNVD |
Mental retardation | 20736978 | CNVD |
severe speech impairment | 20736978 | CNVD |
speech impairment | 20736978 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 21364760 | CNVD |
Mortal | 21835882 | CNVD |
Breast cancer | 21858162 | CNVD |
Autism | 22102821 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:22049600-22054800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr14:22053800-22054200 | Enhancers | NHEK | skin |
3 | chr14:22054800-22055200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr14:22055200-22055600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |